PT - JOURNAL ARTICLE AU - Roman Mathaes AU - Hanns-Christian Mahler AU - Yves Roggo AU - Joerg Huwyler AU - Juergen Eder AU - Kamila Fritsch AU - Tobias Posset AU - Silke Mohl AU - Alexander Streubel TI - Influence of Different Container Closure Systems and Capping Process Parameters on Product Quality and Container Closure Integrity (CCI) in GMP Drug Product Manufacturing AID - 10.5731/pdajpst.2015.005918 DP - 2016 Mar 01 TA - PDA Journal of Pharmaceutical Science and Technology PG - 109--119 VI - 70 IP - 2 4099 - http://journal.pda.org/content/70/2/109.short 4100 - http://journal.pda.org/content/70/2/109.full SO - PDA J Pharm Sci Technol2016 Mar 01; 70 AB - Capping equipment used in good manufacturing practice manufacturing features different designs and a variety of adjustable process parameters. The overall capping result is a complex interplay of the different capping process parameters and is insufficiently described in literature. It remains poorly studied how the different capping equipment designs and capping equipment process parameters (e.g., pre-compression force, capping plate height, turntable rotating speed) contribute to the final residual seal force of a sealed container closure system and its relation to container closure integrity and other drug product quality parameters. Stopper compression measured by computer tomography correlated to residual seal force measurements.In our studies, we used different container closure system configurations from different good manufacturing practice drug product fill & finish facilities to investigate the influence of differences in primary packaging, that is, vial size and rubber stopper design on the capping process and the capped drug product. In addition, we compared two large-scale good manufacturing practice manufacturing capping equipment and different capping equipment settings and their impact on product quality and integrity, as determined by residual seal force.The capping plate to plunger distance had a major influence on the obtained residual seal force values of a sealed vial, whereas the capping pre-compression force and the turntable rotation speed showed only a minor influence on the residual seal force of a sealed vial. Capping process parameters could not easily be transferred from capping equipment of different manufacturers. However, the residual seal force tester did provide a valuable tool to compare capping performance of different capping equipment. No vial showed any leakage greater than 10−8 mbar L/s as measured by a helium mass spectrometry system, suggesting that container closure integrity was warranted in the residual seal force range tested for the tested container closure systems.LAY ABSTRACT: Capping equipment used in good manufacturing practice manufacturing features different designs and a variety of adjustable process parameters. The overall capping result is a complex interplay of the different capping process parameters and is insufficiently described in the literature. It remains poorly studied how the different capping equipment designs and capping equipment process parameters contribute to the final capping result.In this study, we used different container closure system configurations from different good manufacturing process drug product fill & finish facilities to investigate the influence of the vial size and the rubber stopper design on the capping process. In addition, we compared two examples of large-scale good manufacturing process capping equipment and different capping equipment settings and their impact on product quality and integrity, as determined by residual seal force.CCIContainer closure integrityCCSContainer closure systemCTComputer tomographyDPDrug productGMPGood manufacturing practiceLyoLyophilizationNNewtonpCCIphysical CCIRPMRounds per minuteRSFResidual seal force